It is defined as an acute parenchymal infection of the lungs which characterizes with fever >38ºC (>100ºF), productive cough, chest pain, SOB, and signs of parenchymal consolidation.
This first important decision after securing the patient vitals is to determine the treatment setting. To objectively evaluate the admission decision, please follow Pneumonia Severity Index (PSI), or the CURB65 score and SMART-COP for the disease severity and ICU admission. Despite that, evaluating the ability to oral intake, medication adherence, active danger if sent home, mental/cognitive status and socio-economic status and the healthcare service accessibility should be considered.
If the patient required intensive care unit (ICU) admission, or having a necrotizing or cavitary infiltrates or empyema. Empirical
therapy for MRSA is recommended pending sputum and/or blood culture results (A-III) 1.